drugset / Trial / NCT00085488
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Treatment
Summary
RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells may make the body build an immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with stage III or stage IV melanoma.
Timeline
- Start
- 2004-02
- Primary completion
- 2006-02
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous tumor cell vaccine | Vaccine | — | Intravenous |
| Subject | therapeutic autologous dendritic cells | Vaccine | — | Intravenous |